MoneyWorks4Me

Guj. Themis Biosyn - Quaterly Results

06 Feb 2026 Evaluate
The company witnessed a 9.74% growth in the revenue at Rs. 433.68 millions for the quarter ended December 2025 as compared to Rs. 395.20 millions during the year-ago period.The Company's Net profit for the December 2025 quarter have declined marginally to Rs. 124.64  millions as against Rs. 129.73 millions reported during the corresponding quarter ended.Operating profit surged to 217.21 millions from the corresponding previous quarter of 191.08 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 433.68 395.20 9.74 1215.90 1130.63 7.54 1508.00 1698.22 -11.20
Other Income 4.16 2.42 71.90 15.06 10.85 38.80 24.32 43.66 -44.30
PBIDT 217.21 191.08 13.67 576.77 538.93 7.02 712.76 831.00 -14.23
Interest 9.60 1.44 566.67 10.42 2.92 256.85 3.64 2.29 58.95
PBDT 207.61 189.64 9.48 566.35 536.01 5.66 709.12 828.71 -14.43
Depreciation 38.88 15.63 148.75 88.81 41.47 114.15 53.75 35.36 52.01
PBT 168.73 174.01 -3.03 477.54 494.54 -3.44 655.37 793.35 -17.39
TAX 44.09 44.28 -0.43 119.63 126.77 -5.63 167.66 201.71 -16.88
Deferred Tax 15.48 -0.12 -13000.00 35.53 0.49 7151.02 2.80 3.75 -25.33
PAT 124.64 129.73 -3.92 357.91 367.77 -2.68 487.71 591.64 -17.57
Equity 108.97 108.97 0.00 108.97 108.97 0.00 108.97 72.64 50.01
PBIDTM(%) 50.09 48.35 3.59 47.44 47.67 -0.48 47.27 48.93 -3.41
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..